Drug recall D-1611-2014
Product
CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.
Reason for recall
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
Lots and codes
Lot #: 1020156; Expiry: 3/31/2016
Recall details
- Recalling firm
- AbbVie Inc, North Chicago, IL
- Quantity
- 18,021 Bottles
- Distribution
- US: Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- September 15, 2014
- Terminated
- June 22, 2016
Related products
- Creon – drug information
- NDC 0032-3016 Creon · Pancrelipase Lipase 36000 [USP'U]/1; Pancrelipase Amylase… · AbbVie Inc.
- NDC 0032-1203 Creon · Pancrelipase Amylase 15000 [USP'U]/1; Pancrelipase Lipase… · AbbVie Inc.
- NDC 0032-0047 Creon · Pancrelipase Amylase 60000 [USP'U]/1; Pancrelipase Lipase… · AbbVie Inc.
- NDC 0032-2637 Creon · Pancrelipase Lipase 36000 [USP'U]/1; Pancrelipase Amylase… · AbbVie Inc.
- NDC 0032-1212 Creon · Pancrelipase Amylase 60000 [USP'U]/1; Pancrelipase Lipase… · AbbVie Inc.
- NDC 0032-2636 Creon · Pancrelipase Lipase 24000 [USP'U]/1; Pancrelipase Protease… · AbbVie Inc.
- NDC 0032-0046 Creon · Pancrelipase Amylase 30000 [USP'U]/1; Pancrelipase Lipase… · AbbVie Inc.
- NDC 0032-1206 Creon · Pancrelipase Amylase 30000 [USP'U]/1; Pancrelipase Lipase… · AbbVie Inc.
- NDC 0032-1224 Creon · Pancrelipase Lipase 24000 [USP'U]/1; Pancrelipase Protease… · AbbVie Inc.
- NDC 0032-0045 Creon · Pancrelipase Amylase 15000 [USP'U]/1; Pancrelipase Lipase… · AbbVie Inc.